GrowingStockReport.com

NASDAQ Active Stock Watch List: Galena Biopharma, Inc. (NASDAQ:GALE) and Dendreon Corp. (NASDAQ:DNDN) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/30/2013 -- -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Galena Biopharma, Inc. (NASDAQ:GALE) and Dendreon Corp. (NASDAQ:DNDN).

Galena Biopharma, Inc. (NASDAQ:GALE) a biopharmaceutical company that focuses on developing oncology treatments to address major unmet medical needs to advance cancer care is currently up (+11.66%) on 5,299,410 shares traded. Galena Biopharma, Inc. (NASDAQ:GALE) is currently up (+217.88%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Galena Biopharma, Inc. (NASDAQ:GALE)

Dendreon Corp. (NASDAQ:DNDN) a biotechnology company that engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients is currently down (-7.12%) on 4,930,087 shares traded. Dendreon Corp. (NASDAQ:DNDN) is currently down (-58.45%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Dendreon Corp. (NASDAQ:DNDN)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com